10 employees
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.
2014
$5.7M
from 3 investors over 3 rounds
Glionova Therapeutics raised $5.7M on December 9, 2014
Investors: HealthCap, Industrifonden and Novo Holdings